Cargando…
Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
PURPOSE: Our previous studies suggested that p53-positive triple-negative breast cancer (TNBC) should be more sensitive to chemotherapy than p53-negative TNBC. The aim of this study was to determine whether p53 expression in TNBC could predict response to neoadjuvant chemotherapy and the resulting p...
Autores principales: | Bae, Soo Youn, Lee, Jeong Hyeon, Bae, Jeoung Won, Jung, Seung Pil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263888/ https://www.ncbi.nlm.nih.gov/pubmed/32528908 http://dx.doi.org/10.4174/astr.2020.98.6.291 |
Ejemplares similares
-
Prognosis according to the timing of recurrence in breast cancer
por: Lee, Young Joo, et al.
Publicado: (2023) -
Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database
por: Bae, Soo Youn, et al.
Publicado: (2018) -
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016) -
Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
por: Hatzipanagiotou, Maria Eleni, et al.
Publicado: (2023) -
Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)